Designated Gene definition
Examples of Designated Gene in a sentence
The foregoing license is referred to in this Agreement as the “Genentech License.” Notwithstanding anything to the contrary in this Agreement, the Genentech License does not include a license to alter any genomic DNA other than the genomic DNA of a Designated Gene.
In the event of such termination, ARIAD shall grant Incyte a perpetual worldwide, exclusive license to all ARIAD know-how and interest in such Designated Gene Product(s) and corresponding ARIAD patent rights[*].
As set forth under the heading “Genentech Responsibilities (Research Stage 2)” in the Research Plan, Genentech shall review the [***] Evidence for a given Designated Gene.
Incyte grants to Senomyx and Senomyx Affiliate(s) a [...***...] worldwide, non-exclusive license under the Incyte Technology, with respect to Designated Gene Products in the Flavor and Fragrance Field of Use to discover, develop, make, have made, use, sell, have sold, distribute and have distributed F&F Product(s): provided however, that such grant does not include the right to sell Gene Product(s).
Notwithstanding the foregoing, not more than twenty (20) Designated Gene Product(s) shall be subject to a Therapeutic Option at any one time.
During the Selection Period, Genentech may send a written notice to the attention of Sangamo’s Vice President of Business Development requesting that a particular gene (“Requested Gene”) be included as a Designated Gene under this Agreement (“Genentech Request Notice”).
Subject to the provisions of Section 3.5, diaDexus may exercise the Therapeutic Option with respect to any Designated Gene Product which is subject to a Therapeutic Option solely by giving Incyte express notice of exercise, specifying such Designated Gene Product to which the license shall apply, and by paying to Incyte a license fee of ****** prior to the expiration of the applicable option period.
For each Designated Gene, Genentech shall pay to Sangamo a success milestone payment of [***] (“Success Milestone Payment”) in either (but not both) of the following events: (i) Sangamo receives a Success Notice 1 for such Designated Gene; or (ii) Sangamo receives a Success Notice 2 for such Designated Gene.
Notwithstanding anything to the contrary, Genentech shall not have any obligation to pay an Up-Front Fee for a Designated Gene that is a Substituted Designated Gene.
If Genentech, despite using Commercially Diligent Efforts, is not successful in achieving the results required for a Success Notice 1 or Success Notice 2 for a given Designated Gene, no Success Milestone Payment shall be due for such Designated Gene.